Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
Status:
Completed
Trial end date:
2020-09-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the use of olanzapine for the treatment of cancer
patients with chronic nausea and/or vomiting unrelated to chemotherapy or radiation in a
randomized placebo-controlled pilot trial.